Common Contracts

LICENSE AGREEMENT REGARDING THE DETECTION OF THE EBOLA VIRUS

License Agreement • June 19th, 2015 • British Columbia

• Contract Type
  License Agreement
• Filed
  June 19th, 2015
• Jurisdiction
  British Columbia

This License Agreement (hereinafter “Agreement”) is entered into as of June 11, 2015 (the “Effective Date”), by and between BioLytical Laboratories, Inc., having its principal office at 1108 - 13351 Commerce Parkway, Richmond, British Columbia V6V 2X7 Canada, (“BioLytical” or "Licensor") and Network Oncology Inc., having its principal office at Suite 500 - 900 West Hastings Street, Vancouver, British Columbia, V6C 1E5 Canada (“NOI” or "Licensee") (each a “Party” and collectively, the “Parties”).